Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 1;111(2):129-136.
doi: 10.1093/jnci/djy084.

Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations

Britton Trabert  1 , Tim Waterboer  2 , Annika Idahl  3 , Nicole Brenner  2 , Louise A Brinton  1 , Julia Butt  2 , Sally B Coburn  1 , Patricia Hartge  1 , Katrin Hufnagel  2 , Federica Inturrisi  2 , Jolanta Lissowska  4 , Alexander Mentzer  5 , Beata Peplonska  6 , Mark E Sherman  7 , Gillian S Wills  8 , Sarah C Woodhall  9   10   11 , Michael Pawlita  12 , Nicolas Wentzensen  1
Affiliations

Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations

Britton Trabert et al. J Natl Cancer Inst. .

Abstract

Background: Pelvic inflammatory disease (PID) has been associated with ovarian cancer risk. To clarify the role of Chlamydia trachomatis and other infectious agents in the development of ovarian cancer, we evaluated the association of serologic markers with incident ovarian cancer using a staged approach in two independent populations.

Methods: Studies included: 1) a case-control study in Poland (244 ovarian cancers/556 control subjects) and 2) a prospective nested case-control study in the PLCO Cancer Screening Trial (160 ovarian cancers/159 control subjects). Associations of serologic marker levels with ovarian cancer risk at diagnostic as well as higher thresholds, identified in Poland and independently evaluated in PLCO, were estimated using multivariable adjusted logistic regression.

Results: In the Polish study, antibodies (based on laboratory cut-point) against the chlamydia plasmid-encoded Pgp3 protein (serological gold standard) were associated with increased ovarian cancer risk (adjusted odds ratio [OR] = 1.63, 95% confidence interval [CI] = 1.20 to 2.22); when a positive result was redefined at higher levels, ovarian cancer risk was increased (cut-point 2: OR = 2.00, 95% CI = 1.38 to 2.89; cut-point 3 [max OR]: OR = 2.19, 95% CI = 1.29 to 3.73). In the prospective PLCO study, Pgp3 antibodies were associated with elevated risk at the laboratory cut-point (OR = 1.43, 95% CI = 0.78 to 2.63) and more stringent cut-points (cut-point 2: OR = 2.25, 95% CI = 1.07 to 4.71); cut-point 3: OR = 2.53, 95% CI = 0.63 to 10.08). In both studies, antibodies against other infectious agents measured were not associated with risk.

Conclusions: In two independent populations, antibodies against prior/current C. trachomatis (Pgp3) were associated with a doubling in ovarian cancer risk, whereas markers of other infectious agents were unrelated. These findings lend support for an association between PID and ovarian cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. American Cancer Society. Cancer Facts & Figures. 2017 ed. Atlanta, GA: American Cancer Society; 2017.
    1. Piek JM, van Diest PJ, Zweemer RP, et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol. 2001;1954:451–456. - PubMed
    1. Kurman RJ, Shih I.. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—shifting the paradigm. Hum Pathol. 2011;427:918–931. - PMC - PubMed
    1. Crum CP, McKeon FD, Xian W.. BRCA, the Oviduct, and the space and time continuum of pelvic serous carcinogenesis. Int J Gynecol Cancer. 2012;22:S29–S34. - PubMed
    1. Dubeau L, Drapkin R.. Coming into focus: The nonovarian origins of ovarian cancer. Ann Oncol. 2013;24:28–35. - PMC - PubMed

Publication types

MeSH terms